Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for STABILE ANTI-IFNAR1-FORMULIERUNG
Details for 2016837818
Up to date per 12.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2016837818
Title / Product Name
STABILE ANTI-IFNAR1-FORMULIERUNG
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2016837818
EP Publication Number
3337502
E-Number
1283234
Language
EN
PCT Number
US16047506
Publication Date
27.06.2018 A
24.06.2020 B1
Registration Date
24.06.2020
AT Publication Date
15.07.2020
Application Date
18.08.2016
Registration Number
-
Priorities
19.08.2015
US
201562207164 P
IPC
A61K 39/00 20060101AFI20181220BHEP
Maximum Duration of Protection
18.08.2036
Owner
AstraZeneca AB
151 85 Södertälje
SE
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
DEPAZ, Roberto
c/o Medimmune LLC One Medimmune Way
Gaithersburg, MD 20878
US
DEJESUS, Natalie
c/o Medimmune LLC One Medimmune Way
Gaithersburg, MD 20878
US
BEE, Jared
c/o Medimmune LLC One Medimmune Way
Gaithersburg, MD 20878
US
Information about Fees
Click here to load the fees